FDA proposes rule requiring breast implant manufacturers to post cancer warnings on labels

The FDA issued new guidance on breast implants Wednesday, proposing rules that would require manufacturers to post warnings of the potential risks, including cancer and other complications.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.